Thanks to advances in cancer treatment and early detection, the population of cancer survivors continues to grow, reaching more than 18 million in the United States and projected to exceed 22 million by 2035.
However, many cancer survivors have ongoing medical and mental health needs even after cancer treatment ends. Facing long-term side effects, behavioral health challenges, and hormone therapy, many survivors must manage these health challenges on their own.
Time Care, a value-based cancer care navigation company, is expanding its cancer survivorship program called Next Chapter Care to provide a personalized, long-term approach to survivorship support. The program provides tailored oncology support beyond active treatment to more than 15,000 Time Care members who have completed cancer treatment.
Rather than treating survivors as a separate stage of care, the program extends TimeCare’s existing relationships with members throughout diagnosis, treatment and recovery, the company said.
Dr. Asma Dilawari, a board-certified medical oncologist, joined TimeCare last year as medical director of oncology care and led the company’s expansion of survivor support programs.
“Even when I was in the clinical setting, what I felt like I needed to do was see patients in the clinic frequently after their first round of chemotherapy, radiation, and immunotherapy, trying to get them through this grueling treatment, and then they’re never the same again. With all of this, there are a lot of long-term effects, and we don’t see many patients anymore. We say, ‘Your cancer is cured, congratulations,’ and we send them on their way,” Dilawari told Fierce Healthcare. “They came back for a follow-up visit, but they had a lot of other problems. They weren’t necessarily the same problems they had during chemotherapy, but they were still bothersome. Some of them were excessive weight gain that was affecting physical activity, they were constantly tired, and side effects like neuropathy were still there and were affecting their daily lives. These problems are difficult to deal with.”
Through the Survivorship Program, individuals receive dedicated nurse-led visits focused on medication adherence, emotional and mental health support, cancer monitoring, symptom management, and lifestyle goals for ongoing medical needs.
The company said that while interdisciplinary survivor support was part of Time Care’s model, the company has now formalized key elements of the program, including survivor care plans and treatment summaries, provider visits, and long-term follow-up.
The program expands follow-up care from one-time visits to long-term relationships with care teams, Dilawari said.
“When I came to Time Care, I saw this as a huge opportunity to be able to offer more long-term relationships as a virtual care organization and as an organization with extensive reach across the country,” she said. Mr. Dilawari joins Time Care after serving as a clinical reviewer at the FDA’s Center for Drug Evaluation and Research (CDER). She previously practiced at MedStar and Georgetown/Lombardi Comprehensive Cancer Center, with expertise in breast cancer.
Time Care is expanding its survivorship content library and educational resources to provide members with additional tools and guidance to take a more active role in managing their long-term health following treatment.
The program also provides health education, lifestyle modification support, emotional support, screening and diagnostic support, and connection to peer support groups. Through this program, cancer survivors also have access to ongoing follow-up and flexible accommodation options, such as telephone-based support and self-directed educational resources through Time Care Connect.
Founded in 2020 and a 2024 Fierce 15 award winner, the company aims to guide patients through every step of their ‘cancer journey’, from pre-diagnosis to finding out they may have cancer, to post-diagnosis. Executives say the company partners with health plans, employers and at-risk providers to help reduce the cost of cancer treatment while also improving patient health outcomes.
The company has built a unified oncology infrastructure that reduces friction across the system. It combines 24/7 expert cancer care navigation services, technology and data insights, and oncologist-led treatment interventions. According to the company, Thyme Care’s technology-enabled care teams have integrated with more than 1,000 oncologists as part of Thyme Care Oncology Partners, enabling a hybrid collaborative care model.
Thyme Care is rapidly expanding its business. At the end of 2024, it was managing 10,000 patients; by September 2025, the number of cancer patients actively receiving treatment had increased to 80,000.
Next Chapter Care is delivered through Time Care’s multidisciplinary oncology care model, which includes oncology-trained physicians, nurses, licensed clinical social workers, and care navigators. The program leverages Time Care’s Oncology Nursing Certification Corporation (ONCC) nursing workforce to develop skills to provide structured survivor support as part of long-term oncology care.
Time Care supports members in all 50 states through a care team that works with more than 1,400 oncologists and national and local health plan partners.
